FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076516405> ?p ?o ?g. }

• W2076516405 endingPage "92" @default.
• W2076516405 startingPage "84" @default.
• W2076516405 abstract "<b><i>Background:</i></b> Hepatocellular carcinoma (HCC) significantly contributes to the global burden of cancer. Liver cancer is the third most frequent cause of cancer-related death, with HCC representing more than 90% of primary liver cancers. During the last decade, much progress has been made with respect to the definition of patient populations at risk who may benefit from surveillance strategies, as well as in the diagnosis and treatment of the disease. <b><i>Summary:</i></b> New locoregional and systemic therapies have significantly increased the survival of patients with HCC. A multitude of clinical trials addressing patients with HCC have led to advancements in the allocation of subgroups of patients to their optimal individual treatment strategy. This review provides an overview on recent developments in diagnostic and therapeutic modalities and an outlook on future directions in the management of HCC. <b><i>Key Message:</i></b> New locoregional and systemic therapies in patients with HCC have significantly improved clinical outlook and patient survival. This review provides an overview of recent developments in diagnostics and therapeutics, as well as an outlook on future directions in the management of HCC. <b><i>Practical Implications:</i></b> Transabdominal ultrasound is the method of choice for the surveillance of patients at risk of developing HCC, and any suspicious focal lesion in the liver should be characterized. Contrast-enhanced ultrasound with application of second-generation contrast agents enables visualization of tumor vascularity. The Barcelona Clinic Liver Cancer (BCLC) system is the most widely used classification system to guide the clinical management of HCC. Liver resection should be considered for patients with well-preserved liver function and without portal hypertension or elevated bilirubin. Patients not suitable for resection should undergo local tumor ablation. Candidates who are eligible for liver transplantation may benefit from bridging therapy during their waiting period. Patients in the BCLC B category benefit from locoregional transarterial therapy; transarterial chemoembolization is the treatment of choice. Sorafenib is the only systemic therapy that has been shown to prolong overall survival in patients with advanced disease, and is therefore recommended in patients with well-preserved liver function." @default.
• W2076516405 created "2016-06-24" @default.
• W2076516405 creator A5012255962 @default.
• W2076516405 creator A5048446588 @default.
• W2076516405 creator A5050620070 @default.
• W2076516405 date "2014-01-01" @default.
• W2076516405 modified "2023-10-14" @default.
• W2076516405 title "Hepatocellular Carcinoma: Current Concepts in Diagnosis, Staging and Treatment" @default.
• W2076516405 cites W1559113656 @default.
• W2076516405 cites W1587807025 @default.
• W2076516405 cites W1970292985 @default.
• W2076516405 cites W1974709435 @default.
• W2076516405 cites W1976820549 @default.
• W2076516405 cites W1983218872 @default.
• W2076516405 cites W1993707855 @default.
• W2076516405 cites W1996490045 @default.
• W2076516405 cites W1998417832 @default.
• W2076516405 cites W1999659561 @default.
• W2076516405 cites W2000206053 @default.
• W2076516405 cites W2000881039 @default.
• W2076516405 cites W2004569868 @default.
• W2076516405 cites W2006777132 @default.
• W2076516405 cites W2010098735 @default.
• W2076516405 cites W2010265466 @default.
• W2076516405 cites W2018597711 @default.
• W2076516405 cites W2020197365 @default.
• W2076516405 cites W2024057598 @default.
• W2076516405 cites W2041633076 @default.
• W2076516405 cites W2044694173 @default.
• W2076516405 cites W2047554241 @default.
• W2076516405 cites W2052552898 @default.
• W2076516405 cites W2054903266 @default.
• W2076516405 cites W2065396959 @default.
• W2076516405 cites W2066593706 @default.
• W2076516405 cites W2066826726 @default.
• W2076516405 cites W2086720898 @default.
• W2076516405 cites W2088131723 @default.
• W2076516405 cites W2088644721 @default.
• W2076516405 cites W2090207224 @default.
• W2076516405 cites W2092759077 @default.
• W2076516405 cites W2093059993 @default.
• W2076516405 cites W2101562189 @default.
• W2076516405 cites W2116516775 @default.
• W2076516405 cites W2121360143 @default.
• W2076516405 cites W2125763116 @default.
• W2076516405 cites W2126196500 @default.
• W2076516405 cites W2128125049 @default.
• W2076516405 cites W2128551196 @default.
• W2076516405 cites W2130325374 @default.
• W2076516405 cites W2138508705 @default.
• W2076516405 cites W2147172608 @default.
• W2076516405 cites W2163403599 @default.
• W2076516405 cites W2163945848 @default.
• W2076516405 cites W2186902482 @default.
• W2076516405 cites W2213448039 @default.
• W2076516405 cites W2321495996 @default.
• W2076516405 cites W4245784696 @default.
• W2076516405 doi "https://doi.org/10.1159/000362583" @default.
• W2076516405 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4645580" @default.
• W2076516405 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26672483" @default.
• W2076516405 hasPublicationYear "2014" @default.
• W2076516405 type Work @default.
• W2076516405 sameAs 2076516405 @default.
• W2076516405 citedByCount "18" @default.
• W2076516405 countsByYear W20765164052016 @default.
• W2076516405 countsByYear W20765164052017 @default.
• W2076516405 countsByYear W20765164052018 @default.
• W2076516405 countsByYear W20765164052019 @default.
• W2076516405 countsByYear W20765164052020 @default.
• W2076516405 countsByYear W20765164052021 @default.
• W2076516405 countsByYear W20765164052022 @default.
• W2076516405 countsByYear W20765164052023 @default.
• W2076516405 crossrefType "journal-article" @default.
• W2076516405 hasAuthorship W2076516405A5012255962 @default.
• W2076516405 hasAuthorship W2076516405A5048446588 @default.
• W2076516405 hasAuthorship W2076516405A5050620070 @default.
• W2076516405 hasBestOaLocation W20765164051 @default.
• W2076516405 hasConcept C121608353 @default.
• W2076516405 hasConcept C126322002 @default.
• W2076516405 hasConcept C143998085 @default.
• W2076516405 hasConcept C2776231280 @default.
• W2076516405 hasConcept C2777546739 @default.
• W2076516405 hasConcept C2778019345 @default.
• W2076516405 hasConcept C535046627 @default.
• W2076516405 hasConcept C71924100 @default.
• W2076516405 hasConceptScore W2076516405C121608353 @default.
• W2076516405 hasConceptScore W2076516405C126322002 @default.
• W2076516405 hasConceptScore W2076516405C143998085 @default.
• W2076516405 hasConceptScore W2076516405C2776231280 @default.
• W2076516405 hasConceptScore W2076516405C2777546739 @default.
• W2076516405 hasConceptScore W2076516405C2778019345 @default.
• W2076516405 hasConceptScore W2076516405C535046627 @default.
• W2076516405 hasConceptScore W2076516405C71924100 @default.
• W2076516405 hasIssue "2" @default.
• W2076516405 hasLocation W20765164051 @default.
• W2076516405 hasLocation W20765164052 @default.
• W2076516405 hasLocation W20765164053 @default.
• W2076516405 hasLocation W20765164054 @default.

• next